US FDA approves Biogen-Sage Therapeutics pill for clinical depression
1 year ago
No Comments
Related Posts
Fed sees 'strong capital levels' at banks after stress tests, greenlights share buybacks
December 18, 2020
GM, Stellantis work to reach UAW contract deals
October 26, 2023
Asian stocks muted amid China stimulus talk, U.S. rate risks
August 18, 2023
FAA orders checks on 9,300 Boeing 737 planes for possible switch failures
July 15, 2021
Asian stocks edge down as investors eye central bank hikes
January 31, 2023
Exclusive: Southeast Asia's Grab considering U.S. IPO this year, sources say
January 18, 2021
About The Author
